Tivicay and Tadalafil drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Tivicay and Tadalafil. Common interactions include pain among males.

The phase IV clinical study analyzes what interactions people who take Tivicay and Tadalafil have. It is created by eHealthMe based on reports of 15 people who take Tivicay and Tadalafil from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.



On Oct, 01, 2022

15 people who take Tivicay and Tadalafil together, and have interactions are studied.


What is Tivicay?

Tivicay has active ingredients of dolutegravir sodium. It is often used in hiv infection. eHealthMe is studying from 7,530 Tivicay users for its effectiveness, alternative drugs and more.

What is Tadalafil?

Tadalafil has active ingredients of tadalafil. It is often used in erection problems. eHealthMe is studying from 16,799 Tadalafil users for its effectiveness, alternative drugs and more.

Number of Tivicay and Tadalafil reports submitted per year:

Tivicay and Tadalafil drug interactions.

Common Tivicay and Tadalafil drug interactions by gender *:

female:

n/a

male:

  1. Pain
  2. Anxiety
  3. Dyspnoea
  4. Dyspnoea exertional
  5. Fluid overload
  6. Glomerular filtration rate decreased
  7. Headache
  8. Nausea
  9. Oedema
  10. Osteopenia

Common Tivicay and Tadalafil drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Hospitalisation
  2. Anhedonia
  3. Anxiety
  4. Blood creatinine increased
  5. Bone density decreased
  6. Emotional distress
  7. Pain
  8. Renal impairment

50-59:

  1. Diarrhoea
  2. Diuretic therapy
  3. Dyspnoea
  4. Dyspnoea exertional
  5. Fluid overload
  6. Glomerular filtration rate decreased
  7. Headache
  8. Nausea
  9. Oedema
  10. Osteopenia

60+:

  1. Arthralgia
  2. Myalgia
  3. Peripheral swelling

Common conditions people have *:

  1. Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 4 people, 26.67%
  2. Lipodystrophy Acquired (a regional loss of subcutaneous adipose tissue which usually starts in the face, extends downward acquired): 1 person, 6.67%
  3. Back Disorder: 1 person, 6.67%

* Approximation only. Some reports may have incomplete information.

Do you take Tivicay and Tadalafil?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related studies

Alternative drugs to, pros and cons of the 2 drugs:

Browse all drug interactions of Tivicay and Tadalafil:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Tivicay interactions:

Browse all interactions between Tivicay and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Tadalafil interactions:

Browse all interactions between Tadalafil and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on dolutegravir sodium and tadalafil (the active ingredients of Tivicay and Tadalafil, respectively), and Tivicay and Tadalafil (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Tivicay and Tadalafil.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: